#VisualAbstract: Neoadjuvant Nivolumab and Ipilimumab Improve Outcomes in Resectable Stage III Melanoma
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: malignant melanoma
Narrow margin excision of T1a melanoma not associated with recurrence or melanoma-specific mortality
1. Wide local excision of T1a melanoma near critical structures with narrow (5-mm) margins was not associated with worse outcomes. ...
#VisualAbstract: Adjuvant pembrolizumab improves distant metastasis-free survival in stage IIB-C melanoma
Click to read this study in The Lancet Oncology.
#VisualAbstract: Encorafenib plus binimetinib improves quality of life outcomes compared to vemurafenib in patients with advanced BRAF-mutated melanoma
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Local therapy is effective for the treatment of solitary melanoma progression
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Ipilimumab plus anti-PD-1 therapy is effective in patients with anti-PD-L1 resistant metastatic melanoma
Click to read the study in The Lancet Oncology.
#VisualAbstract: Prolgolimab is efficacious and tolerable in patients with advanced melanoma
Click to read the study in the European Journal of Cancer.
Citrus consumption associated with malignant melanoma
1. In a secondary analysis of two large prospective trials of over 63,000 women and 41,000 men, increased consumption of ...
Patients with late stage melanoma remain at risk for further primary melanoma
Image: PD 1. Patients diagnosed with stage III or IV melanoma are at risk for the development of further primary ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
